Want to see TSE:PSYC full AI Analyst Report?
Psyched Wellness (PSYC) Ratios
Psyched Wellness Ratios
TSE:PSYC's free cash flow for Q2 2026 was $-930.02K. For the 2026 fiscal year, TSE:PSYC's free cash flow was increased by $4.00 and operating cash flow was $-930.02K. See a summary of the company’s cash flow.
| Ratios | Feb 26 | Feb 25 | Feb 24 | Feb 23 | Feb 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.78 | 17.39 | 23.93 | 16.11 | 33.15 |
| Quick Ratio | 4.51 | 15.72 | 20.76 | 14.76 | 33.15 |
| Cash Ratio | 3.49 | 14.15 | 20.19 | 12.96 | 31.04 |
| Solvency Ratio | -7.80 | -9.47 | -11.29 | -21.68 | -0.36 |
| Operating Cash Flow Ratio | -6.29 | -6.91 | -9.99 | -15.60 | -16.88 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 3.09M | $ 7.37M | $ 6.96M | $ 2.99M | $ 5.73M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.21 | 1.06 | 1.04 | 1.06 | 1.03 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | -9.98 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | -9.48 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.44 | 1.41 | 1.84 | 0.60 | 84.91 |
| Profitability Margins | |||||
| Gross Profit Margin | 40.18% | 38.82% | 48.49% | 52.84% | 0.00% |
| EBIT Margin | -1076.95% | -725.50% | -1036.76% | -30093.91% | 0.00% |
| EBITDA Margin | -1075.81% | -724.70% | -1035.20% | -30084.53% | 0.00% |
| Operating Profit Margin | -1076.95% | -725.50% | -1036.76% | -28586.49% | 0.00% |
| Pretax Profit Margin | -1066.18% | -683.62% | -1069.15% | -30096.68% | 0.00% |
| Net Profit Margin | -1066.18% | -683.62% | -1069.15% | -30096.68% | 0.00% |
| Continuous Operations Profit Margin | -1066.18% | -683.62% | -1069.15% | -30096.68% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 99.00% | 94.23% | 103.12% | 105.28% | 100.29% |
| Return on Assets (ROA) | -134.29% | -54.02% | -46.78% | -129.76% | -70.47% |
| Return on Equity (ROE) | -162.18% | -57.28% | -48.80% | -138.01% | -72.50% |
| Return on Capital Employed (ROCE) | -163.82% | -60.79% | -47.32% | -131.09% | -72.29% |
| Return on Invested Capital (ROIC) | -163.82% | -60.79% | -47.32% | -131.09% | -72.29% |
| Return on Tangible Assets | -134.29% | -54.34% | -47.06% | -133.61% | -76.17% |
| Earnings Yield | -87.22% | -89.76% | -42.30% | -37.54% | -24.89% |
| Efficiency Ratios | |||||
| Receivables Turnover | 59.19 | 13.22 | 12.84 | 0.22 | 0.00 |
| Payables Turnover | 0.56 | 1.30 | 1.19 | 0.11 | 0.00 |
| Inventory Turnover | 0.34 | 0.51 | 0.17 | 0.03 | 0.00 |
| Fixed Asset Turnover | 24.26 | 25.06 | 10.61 | 0.59 | 0.00 |
| Asset Turnover | 0.13 | 0.08 | 0.04 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.09 | 0.09 | 0.06 | 0.00 | 0.00 |
| Cash Conversion Cycle | 417.07 | 467.96 | 1846.46 | 12922.51 | 0.00 |
| Days of Sales Outstanding | 6.17 | 27.60 | 28.42 | 1635.16 | 0.00 |
| Days of Inventory Outstanding | 1063.71 | 720.72 | 2125.30 | 14464.94 | 0.00 |
| Days of Payables Outstanding | 652.81 | 280.36 | 307.26 | 3177.59 | 0.00 |
| Operating Cycle | 1069.87 | 748.32 | 2153.72 | 16100.10 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -1117.83 | -40.81 | -33.40 | -105.20 |
| Capital Expenditure Coverage Ratio | 0.00 | -1117.83 | -40.81 | -33.40 | -105.20 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -8.58 | -4.98 | -9.45 | -216.46 | 0.00 |
| Free Cash Flow Yield | -70.20% | -65.47% | -38.29% | -27.81% | -16.80% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.18 | -1.11 | -2.36 | -2.66 | -4.02 |
| Price-to-Sales (P/S) Ratio | 12.22 | 7.62 | 25.28 | 801.71 | 0.00 |
| Price-to-Book (P/B) Ratio | 1.86 | 0.64 | 1.15 | 3.68 | 2.91 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.42 | -1.53 | -2.61 | -3.60 | -5.95 |
| Price-to-Operating Cash Flow Ratio | -1.42 | -1.53 | -2.68 | -3.70 | -6.01 |
| Price-to-Earnings Growth (PEG) Ratio | 0.21 | 0.07 | 0.07 | 0.23 | -0.69 |
| Enterprise Value Multiple | -0.69 | 0.36 | -0.60 | -2.07 | -192.57 |
| Enterprise Value | 3.52M | -1.61M | 1.99M | 8.88M | 12.54M |
| EV to EBITDA | -0.69 | 0.36 | -0.60 | -2.07 | -192.57 |
| EV to Sales | 7.45 | -2.59 | 6.19 | 621.83 | 0.00 |
| EV to Free Cash Flow | -0.87 | 0.52 | -0.64 | -2.79 | -4.13 |
| EV to Operating Cash Flow | -0.87 | 0.52 | -0.66 | -2.87 | -4.17 |
| Tangible Book Value Per Share | 0.01 | 0.03 | 0.04 | 0.02 | 0.05 |
| Shareholders’ Equity Per Share | 0.01 | 0.03 | 0.04 | 0.02 | 0.05 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.02 | -0.02 | -0.02 | -0.03 | -0.04 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.99 | 0.94 | 1.03 | 1.00 | 1.00 |
| Research & Development to Revenue | 4.90 | 2.66 | 0.26 | 66.71 | 0.00 |
| SG&A to Revenue | 6.10 | 4.89 | 7.47 | 187.21 | 0.00 |
| Stock-Based Compensation to Revenue | 1.60 | 0.98 | 2.23 | 84.34 | 0.00 |
| Income Quality | 0.80 | 0.73 | 0.88 | 0.72 | 0.67 |
Currency in CAD
